Cargando…
Combating poor-quality anti-malarial medicines: a call to action
The circulation of poor-quality medicines continues to undermine the fight against many life-threatening diseases. Anti-malarial medicines appear to have been particularly compromised and present a major public health threat in malaria-endemic countries, negatively affecting individuals and their co...
Autores principales: | Bassat, Quique, Tanner, Marcel, Guerin, Philippe J., Stricker, Kirstin, Hamed, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888506/ https://www.ncbi.nlm.nih.gov/pubmed/27251199 http://dx.doi.org/10.1186/s12936-016-1357-8 |
Ejemplares similares
-
Development of a pediatric formulation for treatment of P. falciparum malaria: Coartem(®) (artemether-lumefantrine) Dispersible
por: Bassat, Quique, et al.
Publicado: (2014) -
Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network database
por: Tabernero, Patricia, et al.
Publicado: (2014) -
In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis
por: Ketema, Tsige, et al.
Publicado: (2021) -
Highlighting the burden of malarial infection and disease in the neonatal period: making sense of different concepts
por: Nhama, Abel, et al.
Publicado: (2020) -
Lyme Disease: Call for a “Manhattan Project” to Combat the Epidemic
por: Stricker, Raphael B., et al.
Publicado: (2014)